NeuroOne Medical Technologies (NASDAQ:NMTC) Issues Earnings Results

Posted by Donna Armstrong on Feb 12th, 2025

NeuroOne Medical Technologies (NASDAQ:NMTC – Get Free Report) released its earnings results on Wednesday. The company reported $0.06 earnings per share (EPS) for the quarter, Zacks reports. NeuroOne Medical Technologies had a negative net margin of 356.76% and a negative return on equity of 407.04%.

NeuroOne Medical Technologies Trading Down 0.5 %

NMTC stock traded down $0.01 during trading on Wednesday, reaching $1.09. 132,689 shares of the stock were exchanged, compared to its average volume of 260,424. The firm’s 50 day moving average is $0.94 and its 200 day moving average is $0.87. NeuroOne Medical Technologies has a twelve month low of $0.55 and a twelve month high of $1.50. The firm has a market cap of $33.48 million, a P/E ratio of -2.35 and a beta of 0.48.

NeuroOne Medical Technologies Company Profile

(Get Free Report)

NeuroOne Medical Technologies Corporation, a developmental stage company, provides solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson’s disease, dystonia, essential tremors, and chronic pain due to failed back surgeries and other related neurological disorders.